Cepheid

Sunnyvale, United States Founded: 1996 • Age: 30 yrs Acquired By Danaher
Developer of molecular diagnostic testing solutions
Request Access

About Cepheid

Cepheid is a company based in Sunnyvale (United States) founded in 1996 was acquired by Danaher in September 2016.. Cepheid has raised $19.1 million across 8 funding rounds from investors including Medtronic, NIH and Danaher. The company has 208 employees as of April 07, 2024. Cepheid has completed 1 acquisition, including OncoMark. Cepheid operates in a competitive market with competitors including Beckman Coulter, Blackrock Neurotech, Bruker, Complete Genomics and Esco Lifesciences, among others.

  • Headquarter Sunnyvale, United States
  • Employees 208 as on 07 Apr, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cepheid India Private Limited
  • Date of Incorporation 22 Aug, 2013
  • Jurisdiction Gurugram, Haryana, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $54.88 M (USD)
    10.43
    as on Mar 31, 2022
  • Net Profit
    $7.33 M (USD)
    4.46
    as on Mar 31, 2022
  • EBITDA
    $10.37 M (USD)
    6.35
    as on Mar 31, 2022
  • Total Equity Funding
    $19.1 M (USD)

    in 8 rounds

  • Latest Funding Round
    $28 M (USD), Grant

    Jul 30, 2021

  • Investors
    Medtronic

    & 11 more

  • Employee Count
    208

    as on Apr 07, 2024

  • Investments & Acquisitions
  • Acquired by
    Danaher

    (Sep 06, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Cepheid
Headcount 1000-5000
Employee Profiles 662
Employee Profiles
People
Dean Henderson
Global Purchasing Director
People
Christopher Delgado
Principal Industrial Designer
People
Doug Hasegawa
Senior Diagnostic Consumables Engineer
People
Kim Gilonske
Vice President, Commercial Solutions

Unlock access to complete

Funding Insights of Cepheid

Cepheid has successfully raised a total of $19.1M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $28 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 8
  • Last Round Grant — $28.0M
  • First Round

    (21 Jan 2000)

  • Investors Count 11
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Grant - Cepheid Valuation

investors

Jan, 2013 Amount Post-IPO - Cepheid Valuation

investors

Jun, 2012 Amount Grant - Cepheid Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cepheid

Cepheid has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, NIH and Danaher. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Tech-based companies are invested in by Wheatley Partners.
Founded Year Domain Location
Biotechnology investments are targeted by the venture capital firm.
Founded Year Domain Location
PE firm investing in the US
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cepheid

Cepheid has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OncoMark. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Tissue-based cancer diagnostics are developed by OncoMark.
2011
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Cepheid

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cepheid Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cepheid

Cepheid operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beckman Coulter, Blackrock Neurotech, Bruker, Complete Genomics and Esco Lifesciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
domain founded_year HQ Location
Medical devices for neurological therapies are developed.
domain founded_year HQ Location
Diversified research instrument systems are manufactured and supplied.
domain founded_year HQ Location
DNA sequencing platform for human genome analysis is developed.
domain founded_year HQ Location
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cepheid

Frequently Asked Questions about Cepheid

When was Cepheid founded?

Cepheid was founded in 1996 and raised its 1st funding round 4 years after it was founded.

Where is Cepheid located?

Cepheid is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.

Is Cepheid a funded company?

Cepheid is a funded company, having raised a total of $19.1M across 8 funding rounds to date. The company's 1st funding round was a Grant of $19.93K, raised on Jan 21, 2000.

How many employees does Cepheid have?

As of Apr 07, 2024, the latest employee count at Cepheid is 208.

What is the annual revenue of Cepheid?

Annual revenue of Cepheid is $54.88M as on Mar 31, 2022.

What does Cepheid do?

Cepheid was founded in 1996 in Sunnyvale, United States, within the molecular diagnostics sector. Testing solutions are provided across categories including hospital-acquired infections, critical infectious diseases such as multi-drug resistant tuberculosis, influenza, respiratory syncytial virus, and enteroviral meningitis, as well as sexual health and genetic assessments like a 30-minute test for thrombosis risk. Operations focus on healthcare applications in the United States.

Who are the top competitors of Cepheid?

Cepheid's top competitors include Blackrock Neurotech, Agilent and Esco Lifesciences.

How many acquisitions has Cepheid made?

Cepheid has made 1 acquisition, including OncoMark.

Who are Cepheid's investors?

Cepheid has 12 investors. Key investors include Medtronic, NIH, Danaher, HHS, and DARPA.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available